Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-11-17 Sale | 2025-11-18 7:04 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam Gen Counsel & Secretary | 4,319 | $8.9147 | $38,503 | 155,234 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 7:02 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO and CFO | 4,062 | $8.9147 | $36,212 | 436,215 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 7:00 pm | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 3,726 | $8.9147 | $33,216 | 146,705 (Direct) | View |
| 2025-11-17 Sale | 2025-11-18 6:59 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 15,894 | $8.9147 | $141,690 | 2,038,759 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:40 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO and CFO | 4,106 | $6.7671 | $27,786 | 436,375 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:38 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam Gen Counsel & Secretary | 4,365 | $6.7671 | $29,538 | 159,553 (Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:37 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 16,058 | $6.7671 | $108,666 | 2,054,653 (Indirect Direct) | View |
| 2025-08-18 Sale | 2025-08-19 7:36 pm | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 3,766 | $6.7671 | $25,485 | 148,363 (Direct) | View |
| 2025-05-16 Sale | 2025-05-19 5:54 pm | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 3,927 | $6.2579 | $24,575 | 152,129 (Direct) | View |
| 2025-05-16 Sale | 2025-05-19 5:48 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 4,552 | $6.2579 | $28,486 | 163,918 (Direct) | View |
| 2025-05-16 Sale | 2025-05-19 5:45 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 4,282 | $6.2579 | $26,796 | 440,481 (Direct) | View |
| 2025-05-16 Sale | 2025-05-19 5:44 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 13,964 | $6.2579 | $87,385 | 2,070,711 (Indirect Direct) | View |
| 2025-02-18 Sale | 2025-02-21 6:10 pm | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 4,370 | $11.96 | $52,278 | 444,763 (Direct) | View |
| 2025-02-18 Sale | 2025-02-21 6:08 pm | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 4,646 | $11.96 | $55,580 | 168,470 (Direct) | View |
| 2025-02-18 Sale | 2025-02-21 6:05 pm | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 12,048 | $11.96 | $144,130 | 2,084,675 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-25 Gift | 2025-11-26 4:10 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 307,225 | $0 | 363,268 (Indirect) | View |
| 2025-11-15 Exercise | 2025-11-18 7:04 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam Gen Counsel & Secretary | 12,087 | $0 | 155,234 (Direct) | View |
| 2025-11-15 Exercise | 2025-11-18 7:02 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO and CFO | 16,875 | $0 | 436,215 (Direct) | View |
| 2025-11-15 Exercise | 2025-11-18 7:00 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 10,536 | $0 | 146,705 (Direct) | View |
| 2025-11-15 Exercise | 2025-11-18 6:59 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 31,694 | $0 | 2,038,759 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:17 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director | 98,995 | $0 | 98,995 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:16 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 2,676,134 | $0 | 2,676,134 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:15 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 162,716 | $0 | 162,716 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:14 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 178,835 | $0 | 178,835 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:06 pm | N/A 2032-09-11 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 103,735 | $0 | 103,735 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:05 pm | N/A 2031-08-15 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 146,607 | $0 | 146,607 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:04 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 186,116 | $0 | 186,116 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:03 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO and CFO | 1,088,667 | $0 | 1,088,667 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 6:00 pm | N/A 2032-10-30 | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam Gen Counsel & Secretary | 579,000 | $0 | 579,000 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 5:59 pm | N/A 2034-01-16 | Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director | 98,995 | $0 | 98,995 (Direct) | View |
| 2025-11-06 Option Award | 2025-11-07 5:58 pm | N/A 2033-06-11 | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 510,200 | $0 | 510,200 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 7:40 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO and CFO | 16,875 | $0 | 436,375 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 7:38 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam Gen Counsel & Secretary | 12,087 | $0 | 159,553 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 7:37 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 31,686 | $0 | 2,054,653 (Direct) | View |
| 2025-08-15 Exercise | 2025-08-19 7:36 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 10,536 | $0 | 148,363 (Direct) | View |
| 2025-07-10 Gift | 2025-07-14 4:18 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 800,461 | $0 | 1,554,022 (Indirect) | View |
| 2025-06-16 Option Award | 2025-06-18 7:42 pm | N/A 2035-06-15 | Day One Biopharmaceuticals Inc. | DAWN | VASCONCELLES MICHAEL Head of Research and Dev. | 572,000 | $0 | 572,000 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:54 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Grossman William Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:53 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Dable Habib J Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:51 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Ramasastry Saira Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:50 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:49 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:47 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Holles Natalie C. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 5:47 pm | N/A 2035-06-01 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 37,500 | $0 | 37,500 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 5:54 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 10,536 | $0 | 152,129 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 5:48 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 12,086 | $0 | 163,918 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 5:45 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 16,875 | $0 | 440,481 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 5:44 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 31,686 | $0 | 2,070,711 (Direct) | View |
Ownership | 2025-02-28 7:50 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Merendino Lauren Chief Commercial Officer | 0 | $0 | 666,256 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-21 6:10 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 16,875 | $0 | 444,763 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-21 6:08 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Dubow Adam GENERAL COUNSEL | 12,086 | $0 | 168,470 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-21 6:05 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 31,686 | $0 | 2,084,675 (Direct) | View |
| 2025-01-15 Option Award | 2025-01-31 4:38 pm | N/A 2035-01-14 | Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO AND SECRETARY | 268,000 | $0 | 268,000 (Direct) | View |
| 2025-01-15 Option Award | 2025-01-31 4:36 pm | N/A 2035-01-14 | Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy CHIEF EXECUTIVE OFFICER | 473,000 | $0 | 473,000 (Direct) | View |